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Blood Culture Proven Early Onset Sepsis and Late Onset Sepsis 
in Very-Low-Birth-Weight Infants in Korea 
Neonatal sepsis remains one of the most important causes of death and co-morbidity in 
very-low-birth-weight (VLBW) infants. The aim of this study was to determine the current 
incidences of early-onset sepsis (EOS) and late-onset sepsis (LOS), the distribution of 
pathogens, and the impact of infection on co-morbidities in VLBW infants. We analyzed 
the data including sepsis episode from 2,386 VLBW infants enrolled in Korean Neonatal 
Network from January 2013 to June 2014. We defined EOS as a positive blood culture 
occurring between birth and 7 days of life and LOS after 7 days of life. Sepsis was found in 
21.1% of VLBW infants. The risk of sepsis was inversely related to birth weight and 
gestational age. EOS was found in only 3.6% of VLBW infants, however the mortality rate 
was as high as 34.1%. EOS was associated with the increased odds for bronchopulmonary 
dysplasia and intraventricular hemorrhage. The vast majority of EOS was caused by Gram-
positive organisms, particularly coagulase-negative staphylococci (30.6%). LOS developed 
in 19.4% of VLBW infants with a 16.1% mortality rate. Pathogens in LOS were dominated 
by coagulase-negative staphylococci (38.3%). Twenty-five percent and fifty percent of 
first LOS episode occurred after 12 days and 20 days from birth, respectively. Younger and 
smaller VLBW infants showed the earlier occurrence day for the 25% of first LOS episode. 
This study provides a recent nationwide epidemiology of sepsis in VLBW infants in Korea. 
Based on this study, successful strategies to reduce infections would improve survival and 
reduce morbidity.
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INTRODUCTION
Neonatal care has advanced, improving the survival of very-low- 
birth-weight (VLBW) infants. However, such patients remain at 
a high risk for sepsis (1). Up to 20% of mortalities in VLBW in-
fants are caused by sepsis, and infants with sepsis are at a near-
ly-threefold risk of mortality than those without sepsis (2,3). 
Moreover, neonatal sepsis is a major cause of morbidity and 
poor neurodevelopmental outcomes among VLBW infants (4).
 Early-onset sepsis (EOS) typically caused by organisms trans-
mitted vertically before or at the time of birth, is present in ap-
proximately 2%-7% of infants. EOS has been associated with 
significantly increased odds for mortality, intraventricular hem-
orrhage (IVH), retinopathy of prematurity (ROP), and broncho-
pulmonary dysplasia (BPD) (5-7). Factors that were found to 
significantly increase the risk of EOS were low gestational age, 
low birth weight, low Apgar score, and maternal chorioamnio-
nitis (7). Late-onset sepsis (LOS), occurring after 7 days of life, 
may be caused by pathogens acquired during delivery or dur-
ing the course of hospital care (1). The risk factors of LOS include 
prematurity, a need for central venous access, and prolonged 
hospitalization (1). Patent ductus arteriosus (PDA), BPD, nec-
rotizing enterocolitis (NEC) were significantly associated with 
increased rate of LOS (2). 
 Pathogens causing neonatal infections and their antibiotic 
susceptibility patterns may change over time and differ among 
countries. It is therefore important to monitor the epidemiology 
of neonatal infections to make decisions on policy and clinical 
practice (8). However, until the Korean Neonatal Network (KNN) 
was established, Korea did not have a national longitudinal neo-
natal infection surveillance system. Thus, only limited data on 
neonatal sepsis in Korea were reported (9,10).
 This study was undertaken to determine the current incidenc-
es of EOS and LOS, the distribution of infecting pathogens, and 
the impact of infection on co-morbidities in VLBW infants cared 
for in the KNN.
MATERIALS AND METHODS
Study population 
Data on EOS and LOS, infecting organisms, maternal and in-
fant demographic data, and clinical data were analyzed using 
KNN registry. A total of 2,386 VLBW infants who were born from 
January 1, 2013 to June 31, 2014 in or transferred to one of the 
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55 KNN centers within 28 days of life were enrolled. Trained 
staff collected data on mothers and infants from birth to hospi-
tal discharge or death. External audits were done periodically to 
review the quality and reliability of data extracted from patient 
records in the KNN.
Outcomes 
EOS was identified by clinical symptoms and a positive blood 
culture drawn in the first 7 days of life, and LOS was defined as 
infection occurring thereafter. Proven sepsis was defined as a 
positive result for one or more bacterial or fungal cultures ob-
tained from blood of the infants with clinical signs of infection 
or treated with appropriate antibiotics for 5 or more days or un-
til death without sign of infection (11). Series of samples that 
were repeatedly positive for the same organism within 7 days 
were considered as part of the same episode. If a different or-
ganism was noted in a subsequent culture, this was considered 
another episode. KNN registry included up to three episode of 
bacteria sepsis and up to two episodes of fungal sepsis. 
 Gestational age was determined by obstetric estimates. We 
defined antifungal prophylaxis as when the systemic antifungal 
agents for the prevention of fungal infections were administered 
shortly after birth. Congenital infection was confirmed via TO-
RCH evaluation. Meningitis was defined as a positive spinal cul-
ture for infants treated with more than 5 days of antibiotic med-
ication. IVH was graded according to the method of Papile et al 
(12). NEC was classified according to the system of Bell et al. (13). 
BPD was defined by NIH classification (14). The main cause of 
death was collected for all infants who died, according to the 
doctor’s documentation.
Statistical analysis 
For analyzing the rates of sepsis/1,000 hospital days and inci-
dences of sepsis, gestational age was categorized as 4 groups; 
24 weeks’ gestation or less, 25-28 weeks’ gestation, 29-32 weeks’ 
gestation, and 33 weeks’ gestation, and birth weight was cate-
gorized as 5 groups; less than 500 g, 500-749 g, 750-999 g, 1,000-
1,249 g and 1,250-1,499 g. Infection rates were expressed as the 
rates of sepsis, EOS and LOS per 1,000 hospital days and per-
centage of all live births in each categories. Univariate analyses 
for continuous variables were performed using Student’s t-test. 
Categorical variables, including the primary outcome, were ex-
amined using a chi-square analysis. Data are presented as mean 
and standard deviation, as the data were found to be normally 
distributed. Multivariate analyses were used to identify the in-
dependent association of EOS or LOS with neonatal outcome 
variables. Multivariate analysis adjusted for the significant fac-
tors through univariate analysis was done. Kaplan-Meier plot-
ting was used to estimate the occurrence of the first LOS episo-
de from lifetime data. Log-rank test was done for compare the 
probability among the categorized group divided by the birth 
weight (less than 500 g, 500-999 g, and 1,000-1,499 g) and gesta-
tional age (24 weeks’ gestation or less, 25-28 weeks’ gestation, 
and 29 weeks’ gestation or more). Comparison of 1, 2, and 3 quar-
tile estimated time for occurring first episode of LOS among the 
birth weight groups and gestational age groups using F-test was 
done. Calculations were performed with SPSS software version 
21.0 (IBM Corp., Chicago, IL, USA) and SAS version 9.2 (SAS In-
stitute, Cary, NC, USA). P values less than 0.05 were considered 
sta-tistically significant. 
Ethics statement 
The KNN study received ethical approval from the local institu-
tional review board in each participating center prior to joining 
the network. Informed consent for participating in KNN was 
written by the parents. 
RESULTS
Incidence of EOS and LOS and demographic characteristics 
Sepsis was found in 21.1% of 2,386 VLBW infants. The risk of 
sepsis was inversely related to birth weight and gestational age 
(Table 1). The rates of all sepsis episodes per 1,000 hospital days 
were also comparable for birth-weight and gestational-age cat-
egories. The rate of sepsis decreased with increasing birth weight 
to 7.35 for infants 500 to 749 g, 4.66 for infants 750 to 999 g, 4.14 
for those 1,000 to 1,249 g, and 2.58 for those 1,250 to 1,499 g. Sim-
ilarly, the infection rate was inversely related to gestational age. 
This rate of infection declined to 7.92 at ≤ 24 weeks, 5.63 at 25 
to 28 weeks, 3.62 at 29 to 32 weeks, and only 1.65 for infants born 
at 33 weeks or more (Table 1). Among 2,386 VLBW infants en-
rolled in KNN, 85 infants had positive blood cultures in the first 
7 days; thus, the incidence of EOS was 36 per 1,000 live births 
(Table 2). Among the 2,281 VLBW infants who survived until 7 
Table 1. Rates of sepsis/1,000 hospital days and incidence of sepsis versus birth weight and gestational age 
Birth weight (g) No. No. with sepsis
Rate/1,000  
hospital days
Incidence (%) GA (week) No. No. with sepsis
Rate/1,000  
hospital days
Incidence (%)
< 500   59   23 6.41 39.0 ≤ 24 116   46 7.92 39.7
500-749 328 133 7.35 40.6 25-28 797 264 5.63 33.1
750-999 542 150 4.66 27.7 29-32 1,103 175 3.62 15.9
1,000-1,249 631 121 4.14 19.2 ≥ 33 370   19 1.65   5.1
1,250-1,499 826   77 2.58   9.3 Total* 2,386 504 4.97 21.1
*Same in the birth weight group. GA, gestational age.
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days of age, 442 infants showed positive blood cultures after 7 
days of age, and 632 microorganisms were noted due to multi-
ple sepsis episodes. The overall incidence of LOS was 194 per 
1,000 live births (Table 3). Only 23 infants (1%) had both EOS 
and LOS. The majority of infants (72%) had a single episode of 
LOS; 21% had two episodes, 5% had three episodes, and 1% 
had four or more episodes. The majority of episodes (60%) oc-
curred in extremely low birth weight infants (96% were born at 
≤ 32 weeks gestation). Infants with lower birth weights were 
more likely to have multiple episodes (< 500 g, 29%; 500-749 g, 
39%; 750-999 g, 20%; 1,000-1,249 g, 9%; 1,250-1,499 g, 3%; 
P < 0.001).
 The first LOS episode based on lifetime data was estimated 
to occur at a median age of 20 days (range 7-198 days; 25th per-
centile: 12 days; 75th percentile: 33 days; Fig. 1). Using a log-rank 
test, we calculated the expected number of LOS episodes as time 
progressed in each group by dividing by the gestational age and 
birth weight. When the VLBW infants were divided into three 
groups according to birth weight (< 500 g, 500-999 g, and ≥ 1,000 
g), there were significant differences in the occurrence of the 
first LOS sepsis episode (P < 0.001). The infants were also divid-
ed into three gestational age groups: ≤ 24 weeks, 25-28 weeks, 
and ≥ 29 weeks. Significant differences among the groups ver-
sus gestational age were found (P < 0.001) (Fig. 2). Comparison 
of quartile estimated time among three groups according to the 
birth weight, showed no significance difference, using F-test. 
Comparison of 25 percent of LOS episode estimated time among 
three groups according to the gestational age, showed signifi-
cant difference (P = 0.012) (Table 4). 
Distribution of pathogens causing EOS, LOS and direct 
mortality 
The majority of EOS events were caused by Gram-positive or-
ganisms (56.5%). Coagulase-negative staphylococcus (CONS) 
was the most common pathogen, accounting for 30.6% of all 
infections. Gram-negative pathogens accounted for 40.0% of 
infections, with most common E. coli occurring in 11.8% of pa-
tients. Fungal pathogens were relatively rare compared to bac-
teria (3.5%). 
 The majority (72.0%) of LOS episodes were caused by Gram-
positive organisms. CONS was the most common late-onset 
pathogen (38.3%) of all infections, comprising 53.2% of Gram-
positive infections. Gram-negative pathogens accounted for 
15.3% of all microorganisms. Klebsiella and Enterobacter spe-
cies were the most common Gram-negative pathogens. Fungal 
organisms were responsible for 12.0% of LOS episodes (Table 5).
 Overall, 100 of the 504 infants with sepsis died (19.8%). The 
main cause of death was confirmed as infection for 13 of 85 VL-
Table 2. Rates of EOS episodes/1,000 hospital days and incidence of sepsis versus birth weight and gestational age
Birth weight (g) No. No. with EOS Rate/1,000 HD Incidence (%) GA (week) No. No. with EOS Rate/1,000 HD Incidence (%)
< 500   59   5 1.00 8.5 ≤ 24 116 12 1.46 10.3
500-749 328 29 1.04 8.8 25-28 797 51 0.75   6.4
750-999 542 22 0.50 4.1 29-32 1,103 20 0.31   1.8
1,000-1,249 631 19 0.47 3.0 ≥ 33 370   2 0.14   0.5
1,250-1,499 826 10 0.26 1.2 Total* 2,386 85 0.70   3.6
*Same in the birth weight group. EOS, early-onset sepsis; GA, gestational age; HD, hospital days.
Table 3. Rates of LOS episodes/1,000 hospital days and incidence of sepsis versus birth weight and gestational age
Birth weight (g) No. No. with LOS Rate/1,000 HD Incidence (%) GA (week) No. No. with LOS Rate/1,000 HD Incidence (%)
< 500   48   19 3.83 39.6 ≤ 24 83   37 4.55 44.6
500-749 286 111 4.02 38.8 25-28 747 226 3.32 30.3
750-999 514 136 3.10 26.5 29-32 1,083 161 2.49 14.9
1,000-1,249 618 107 2.65 17.3 ≥ 33 368   18 1.24   4.9
1,250-1,499 815   69 1.80   8.5 Total* 2,281 442 3.05 19.4
*Same in the birth weight group. LOS, late-onset sepsis; GA, gestational age; HD, hospital days.
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Fig. 1. Days to first episode of LOS in VLBW infants using Kaplan Meier curves. Quar-
tile estimates according to the time variable duration showed as follows; 25 percen-
tile of the first LOS episode occurred after the12 days from birth, 50% percentile af-
ter 20 days from birth, and 75 percentile after 33 days from birth. 
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BW infants with EOS (15.3%). Death rates of EOS differed sig-
nificantly by pathogen type; interestingly, 38.2% of Gram-nega-
tive organisms noted mortality, while all infants with Gram-pos-
itive organisms and fungal infections remained alive. The over-
Table 4. Comparison of 1, 2, and 3 quartile estimated time for occurring first episode of LOS among the birth weight groups and gestational age groups using F-test
Percentile
Birth weight group
P value
Gestational age group
P value
< 500 g 500-999 g 1,000-1,499 g ≤ 24 weeks 25-28 weeks ≥ 29 weeks
25 11 (8-19) 12 (10-12) 13 (11-15) 0.562 9 (8-12) 12 (10-13) 14 (13-17) 0.012
50 19 (11-45) 19 (16-22) 20 (18-22) 0.883 16 (12-20) 19 (17-22) 21 (20-24) 0.114
75 61 (19-138) 33 (28-41) 32 (27-37) 0.070 29 (21-54) 33 (29-41) 34 (28-39) 0.766
LOS, late-onset sepsis.
Table 5.  Distribution of Pathogens and Direct Death Caused by EOS and LOS 
Organisms†
EOS LOS
n (%) Death*, n (%) n (%) Death*, n (%)
Gram positive organisms 48 (56.5) 0 (0) 455 (72.0) 11 (2.4)
   Staphylococcus coagulase negative 26 (30.6) 242 (38.3) 3 (1.2)
   Staphylococcus aureus coagulase positive 9 (10.6) 72(11.4) 4 (5.6)
   Staphylococcus other 5 (5.9) 81 (12.8) 1 (1.2)
   Streptococcus other 6 (7.1) 16 (2.5) 1 (6.3)
   Streptococcus group B 1 (1.2) 5 (0.8) 0
   Enterococcus species 1 (1.2) 39 (6.2) 2 (5.1)
Gram negative organisms 34 (40.0) 13 (38.2) 97 (15.3) 9 (9.3)
   Escherichia coli 10 (11.8) 4 (40.0) 14 (2.2)  0
   Klebsiella species 6 (7.1) 2 (33.3) 24 (3.8) 4 (16.7)
   Pseudomonas species 6 (7.1) 2 (33.3) 6 (0.9) 1 (16.7)
   Acinetobacter species 5 (5.9) 4 (80.0) 11 (1.7)  0
   Enterobacter species 3 (3.5)  0 24 (3.8) 2 (8.3)
   Burkholderia species 3 (3.5)  0 6 (0.9) 1 (16.7)
   Serratia species  0  0 9 (1.4) 1 (11.1)
   Clostridium species 1 (1.2) 1 (100) 0  0
   Stenotrophomonas maltophilia 0  0 3 (0.5)  0
   Other-bacterial 0  0 4 (0.6) 1 (25.0)
Fungus 3 (3.5) 0 (0) 76 (12.0) 5 (6.6)
Total 85 (100) 13 (15.3) 632 (100) 26 (4.1)
*Death was included only if the written cause of death was infection. Death counts differ from the overall mortality (Table 6). Death was shown as the number of mortality and 
percent for each individual pathogen. †Organisms counts differ from the infants with LOS due to the multiple episode of LOS. EOS, early onset sepsis; LOS, late-onset sepsis; n, 
number of organism. 
Fig. 2. Kaplan Meier probability curve for first episode of LOS according to gestational age groups (A) and birth weight groups (B). The younger the gestational age, the higher 
the probability of first LOS episode. The smaller the birth weight, the higher the probability of first LOS episode (log-rank test for trend P < 0.001). 
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all mortality rate for infants with EOS, regardless of cause of death, 
was 34.1% compared to 11.1% for infants with negative cultures 
(P < 0.001; Table 7).
 Overall, 16.0% of the infants with LOS died. The mortality 
rate of LOS for each pathogen indicated that infection was the 
most common cause of death, including infection due to Gram-
negative organisms (9.3%), followed by Candida (6.6%), and 
Gram-positive organisms (2.4%). The mortality rate of CONS 
sepsis was only 1.2% (Table 5). 
 Twelve percent of infants died on the same day as when the 
blood culture was taken; 35% died within 3 days, and 40% died 
within 7 days. Infants infected with Gram-negative organisms 
were more likely to die acutely within 3 days of the positive blood 
culture (58%). 
Patient characteristics and co-morbidities associated with 
EOS and LOS 
The mean gestation, mean birth weight, and mean Apgar score 
were significantly lower in the EOS group than in the control 
group. Vaginal delivery and initial resuscitation were more com-
mon in the EOS group than in the control group (Table 6). Mul-
tivariate analyses for the major morbidities and mortality with 
EOS were adjusted for the gestation and initial resuscitation. 
After adjusted the gestation and initial resuscitation, VLBW with 
EOS were at an increased risk of IVH (≥ G3) (OR 2.10 ,95% CI 
1.27-3.48) and BPD (≥ mod) (OR 1.96, 95%CI 1.16-3.30) (Table 
7). In the LOS group, the mean gestation, birth weight, and Ap-
gar score were significantly lower. Antenatal steroid use, and 
initial resuscitation were found to be significantly more com-
mon in the LOS group (Table 6). After adjusted the gestation, 
antenatal steroid use, and initial resuscitation to determine 
major morbidities and mortality of infants with LOS, VLBW 
with LOS were at an increased risk of IVH (≥ G3) (OR 1.97, 95% 
CI 1.51-2.57), PVL (OR 2.06, 95% CI 1.50-2.83), BPD (≥ mod) 
(OR 2.55, 95% CI 2.01-3.24), and NEC (≥ G2) (OR 2.37, 95% CI 
1.67-3.37) (Table 7). 
DISCUSSION
This was the first large-scale study of neonatal sepsis in VLBW 
infants from 55 neonatal intensive care units (NICUs) in South 
Korea. The KNN was established in April 2013 as an infrastruc-
ture for NICU quality improvement, with the goal of improving 
the survival rate and decreasing the number of sepsis episodes. 
Before the KNN was established, there were only limited reports 
about neonatal sepsis in Korea, due to the small number of en-
rolled NICUs and the short duration of studies and retrospec-
tive studies (9,10). 
Table 6. Patient Characteristics of EOS and LOS  
Control group 
(n = 2,301)
EOS  
(n = 85)
OR (95%CI)
Control group 
(n = 1,839)
LOS  
(n = 442)
OR (95%CI)
Gestational age (week)  28.5 ± 3.1 26.1 ± 2.4 0.72 (0.69-0.81)*  29.0 ± 3.0 27.0 ± 2.7 0.80 (0.77-0.83)*
Birth weight (g) 1,080.0 ± 283.9   867.0 ± 280.4 0.99 (0.99-0.99)* 1,121.3 ± 269.9   935.5 ± 271.3 0.10 (0.99-0.99)*
SGA 378 (16%) 10 (12%) 0.68 (0.35-1.32) 308 (17%) 63 (14%) 0.83 (0.62-1.11)
1 min AS   4.6 ± 2.0   3.8 ± 2.1 0.85 (0.76-0.94)*    4.8 ± 2.0   3.9 ± 1.9 0.81 (0.77-0.86)*
5 min AS   6.7 ± 1.8   5.8 ± 2.1 0.80 (0.73-0.89)*    6.9 ± 1.7   6.1 ± 1.8 0.81 (0.77-0.86)*
Pathologic chorioamnionitis 652 (28%) 31 (36%) 1.50 (0.93-2.38) 514 (28%) 131 (30%) 1.19 (0.94-1.52)
PROM 801 (35%) 37 (44%) 3.85 (0.48-17.31) 651 (35%) 145 (33%) 1.17 (0.32-8.34)
Antenatal steroid 1,682 (73%) 70 (82%) 1.79 (0.95-3.23) 1,338 (73%) 350 (79%) 1.59 (1.22-2.09)*
C/Sec 1,729 (75%) 52 (61%) 0.59 (0.44-0.82)* 1,378 (75%) 337 (76%) 1.08 (0.84-1.37)
Initial resuscitation 1,997 (87%) 81 (95%) 2.35 (1.17-4.58)* 1,560 (85%) 415 (94%) 2.11 (1.27-5.15)*
Data expressed as number (%). *P < 0.05. EOS, early-onset sepsis; LOS, late-onset sepsis; n, number; SGA, small for gestational age; AS, Apgar score; PROM, premature rup-
ture of amniotic membrane; C/sec, Cesarean section.
Table 7. Major Morbidities and Mortality of VLBWI With and Without EOS or LOS
Outcome variable
EOS LOS
Yes  
(n = 85)
NO  
(n = 2,301)
Adjusted OR† for outcome  
variable (95% CI) 
Yes  
(n = 442)
No  
(n = 1,839)
Adjusted OR‡ for outcome  
variable (95% CI)
IVH ( ≥ Grade 3) 20 (24) 220 (10) 2.10 (1.27-3.48)* 88 (20) 133 (7) 1.97 (1.51-2.57)*
PVL 12 (14) 203 (9) 1.36 (0.71-2.59) 76 (17) 136 (7) 2.06 (1.50-2.83)*
BPD ( ≥ moderate) 34 (40) 653 (28) 1.96 (1.16-3.30)*  228 (52) 459 (25) 2.55 (2.01-3.24)*
NEC ( ≥ Grade 2) 11 (13) 154 (7) 1.10 (0.54-2.22) 71 (16) 88 (5) 2.37 (1.67-3.37)*
ROP with operation 13 (15) 186 (8) 0.90 (0.46-1.72) 72 (16) 127 (7) 1.27 (0.89-1.92)
Mortality 29 (34) 255 (11) 1.03 (0.80-3.45) 71 (16) 108 (6) 1.67 (0.88-2.36)
Data expressed as number (%).*P < 0.05; †Analyses for the major morbidities and mortality with and without EOS were adjusted for gestation and initial resuscitation; ‡Analy-
ses for the morbidities and mortality with and without LOS was adjusted for gestation, antenatal steroid use, and initial resuscitation. EOS, early-onset sepsis; LOS, late-onset 
sepsis; IVH, intraventricular hemorrhage; PVL, periventricular leukomalacia; BPD, bronchopulmonary dysplasia; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity. 
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 There have been several nationwide epidemiological studies 
of infections among NICUs in other countries such as the Neo-
natal Research Network of the National Institute of Child Health 
and Human Development (NICHD) in the USA and the neona-
tal networks in Canada, Australia, New Zealand, and Japan (14-
17). There has been considerable variability in the reported in-
cidence of sepsis (2). VLBW infants born in the Neonatal Re-
search Network (NRN) Centers of Japan in 2012 demonstrated 
an overall 8% incidence rate of sepsis (18). Among 5447 VLBW 
infants born at NICHD centers in the USA between 1998 and 
2000, sepsis was present in 22% of all patients (3). Infants at less 
than 32 weeks of gestation in Level III NICUs of the Australian 
and New Zealand neonatal network (ANZNN) in 2012 showed 
a 12% rate of sepsis (17). In this study, during the 18 months of 
collection from January 2013, the overall incidence of sepsis 
was 21% of infants. The incidence of sepsis in the KNN was high-
er than that of the Japanese NRN and similar to those of the NI-
CHD and other networks.
 Early onset sepsis is variably defined as either occurring with-
in 7 days after birth or within 48-72 hr of birth. EOS, defined as 
occurring within 7 days in Japan, was 3.6% (18). In the NICHD 
study, EOS was defined as occurring within 72 hr of birth and 
was noted in 1.5% of infants (3). From the data of ANZNN, EOS 
was defined as occurring within 48 hr of birth and was reported 
for 0.9% of infants (17). Sepsis was diagnosed more frequently 
at the low gestational age. The rate of EOS was 6% at 22 weeks 
and 1% at 28 weeks (19). In our study, EOS occurred in 3.6% of 
infants, with rates of 10.3% and more than 28 weeks.
 The incidence of LOS showed variable range according to 
country and hospital. From the NICHD study, LOS was present 
in 22% of infants, and the rates of LOS were 58% at 22 weeks 
and 20% at 28 weeks (20). In our study, the incidence of LOS 
was shown to be 19.4% among the 2,281 infants who survived 
for more than 7 days after birth. In a report from the Nether-
lands, the incidence of LOS in VLBW infants was 14.9 per 1,000 
patient days. In the German study, in their first year of reporting 
LOS incidence in VLBW infants, the rate was 8.3 per 1,000 pa-
tient days, and the overall incidence of sepsis was 4.7 per 1,000 
patient days (21). In the NICHD study, the rate of the first epi-
sode of LOS was 3.8 per 1,000 patient days (11). In this study, 
the rate of LOS episodes was 3.1 per 1,000 patient days. The in-
fection rate was inversely related to birth weight and gestation. 
Infants below 500 g found to have a short duration of hospital-
ization due to high mortality; thus, rates per hospital day for in-
fants below 500 g were lower than those for infants between 500 
and 749 g. 
 The patterns of pathogens responsible for neonatal sepsis 
have changed with time and vary from place to place (22). In 
the United Kingdom, organisms causing EOS are predominat-
ed by group B streptococcus. However, in the NICHD, a marked 
reduction in group B streptococcal sepsis (from 5.9 to 1.0 per 
1,000; P < 0.001) and an increase in Escherichia coli sepsis (from 
3.2 to 6.8 per 1,000; P = 0.004) were noted (23). Infants with EOS 
were more likely to die than uninfected infants (37% vs. 13%; 
P < 0.001), especially if they were infected with Gram-negative 
organisms (11). In a recent study from Canada, however, CONS 
was found to be the most common organism identified in EOS 
among both full-term and preterm infants. However, mortality 
rate due to CONS was low in infants with EOS (6). In our study, 
Gram-positive organisms were the most predominant organ-
isms of EOS in Korea. Coagulase-negative Staphylococcus was 
noted as the highest at 31%, followed by Staphylococcus aureus. 
 Microorganism populations isolated in infants with LOS were 
dominated by Gram-positive cocci, predominantly CONS (62.5%) 
(14,24,25). In the NICHD study, CONS was the most common 
LOS pathogen (48% of all infections). Infections caused by yeast-
like fungi constituted 7.9% of all the cases (14,21). Gram-nega-
tive pathogens (35%) and fungi (35%) were the pathogens most 
associated with mortality in LOS, followed by CONS (18%). In 
our study, CONS (38%) was the most common pathogen of LOS, 
and Staphylococcus aureus appeared in 11% of cases. The mor-
tality rate of CONS sepsis was only 1.2%, and that of Staphylo-
coccus aureus sepsis was 5.6%. The mortality rate of Gram-neg-
ative sepsis was 9.3%, and that of fungal sepsis was 6.6%. Accord-
ing to a previous report, methicillin-resistant Staphylococcus 
aureus (MRSA) accounts for 80% of isolated Staphylococcus au-
reus cases in intensive care units and has become a threat to 
critically ill populations in Korea, including neonates. Kim et al. 
reported that LOS due to MRSA in Korea comprised 18.8% of 
cases (26). In this study, it has limitation about no information 
of LOS due to MRSA. 
 Neonatal sepsis is associated with increased mortality and 
morbidity among premature infants. From the data collected 
by the Israel Neonatal Network, EOS was associated with signif-
icantly increased odds of severe IVH (OR: 2.24), severe ROP (OR: 
2.04), and BPD (OR: 1.74). EOS was also associated with an in-
creased risk of death and/or severe neurologic morbidity (OR: 
2.92) (5). The percentage of infants with EOS was higher among 
those with PROM > 48 hr than among those with PROM < 48 
hr (P < 0.001) (25). In our study, mean gestation, birth weight, 
mean APGAR score, cesarean section and initial resuscitation 
were significantly different between the EOS group and the con-
trol group. In analyzing the risk factor of EOS, gestational age 
was strongly associated with the risk of EOS (OR: 0.72). In ac-
cord with other studies, VLBW with EOS were at an increased 
risk of IVH (≥ G3) (OR 2.10) and BPD (≥ mod) (OR 1.96). How-
ever, there was no significant association with increased risk of 
death. 
 From the data collected by the Polish Neonatology Surveil-
lance Network, the occurrence of LOS was significantly associ-
ated with increased length of mechanical ventilation (OR: 2.65) 
and continuous positive airway pressure (OR: 2.51), as well as 
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the duration of antibiotic use (OR: 2.98) (27). Surgical proce-
dures and lower gestational age were significantly associated 
with the risk of LOS (21). Infants who developed LOS were sig-
nificantly more likely to develop BPD. In the NICHD study, in-
fants with PDA (OR: 1.2), BPD (OR: 1.3), and NEC (OR: 2.7) had 
a higher incidence of LOS. There was no association between 
LOS and RDS, severe IVH, or PVL. In our study, VLBW infants 
with LOS were at an increased risk of IVH (≥ G3) (OR 1.97), PVL 
(OR 2.06), BPD (≥ mod) (OR 2.55), and NEC (≥ G2) (OR 2.37). It 
is quite similar to other studies. 
 A large multicenter study from the German Neonatal Net-
work showed that SGA was a risk factor of LOS (OR: 1.31; 95% 
CI: 1.02-1.68; P = 0.03) (11). In contrast, a Norwegian popula-
tion-based study on ELBW infants found no association between 
SGA and sepsis (28). In our study, SGA showed no significant 
risk of sepsis.
 The majority of extreme low birth weight (ELBW) survivors in 
our study (65%) had at least one infection during their NICU 
birth stay. The occurrence of more than one infection was ob-
served frequently among those with ELBW and LOS. However, 
no significant difference was noted in the occurrence of the tim-
ing of the first LOS episode among the birth weight groups and 
gestation groups. 
 Our study had several limitations. Differences of policy and 
treatment between the NICUs still remained. No more than five 
episodes of infection were collected, although these included 
most of the episodes of sepsis. Data regarding antenatal antibi-
otics use and antibiotics sensitivity were not collected. 
 This study provides a recent nationwide epidemiology of sep-
sis in VLBW infants in Korea. Based on this study, successful strat-
egies to reduce infections among VLBW infants would improve 
survival and reduce neonatal morbidity. International compar-
isons and efforts for quality improvement will be needed. 
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